Fidelity Investments’s AngioDynamics ANGO Stock Holding History

Fidelity Investments’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.08M	Sell	94,748 -33,624	-26%	-$364K	﹤0.01%	2854
2025 Q4	$1.65M	Buy	128,372 +30,284	+31%	+$374K	﹤0.01%	2676
2025 Q3	$1.1M	Buy	98,088 +12,250	+14%	+$118K	﹤0.01%	2768
2025 Q2	$852K	Buy	85,838 +3,146	+4%	+$30.8K	﹤0.01%	2775
2025 Q1	$776K	Buy	82,692 +52,699	+176%	+$554K	﹤0.01%	2760
2024 Q4	$275K	Sell	29,993 -22,786	-43%	-$168K	﹤0.01%	3148
2024 Q3	$411K	Buy	52,779 +27,031	+105%	+$195K	﹤0.01%	2934
2024 Q2	$156K	Buy	25,748 +2,455	+11%	+$15.1K	﹤0.01%	3119
2024 Q1	$137K	Sell	23,293 -2,593	-10%	-$15.4K	﹤0.01%	3167
2023 Q4	$203K	Buy	25,886 +21,558	+498%	+$150K	﹤0.01%	2960
2023 Q3	$31.6K	Buy	4,328 +1,278	+42%	+$10.6K	﹤0.01%	3579
2023 Q2	$31.8K	Buy	3,050 +1,738	+132%	+$16.7K	﹤0.01%	3655
2023 Q1	$13.6K	Sell	1,312 -28	-2%	-$358	﹤0.01%	4015
2022 Q4	$18.5K	Sell	1,340 -2,691,562	-100%	-$37.4M	﹤0.01%	3806
2022 Q3	$55.1M	Buy	2,692,902 +879,356	+48%	+$19.3M	0.01%	1212
2022 Q2	$35.1M	Buy	1,813,546 +130,429	+8%	+$2.67M	﹤0.01%	1414
2022 Q1	$36.3M	Buy	1,683,117 +602,102	+56%	+$13.7M	﹤0.01%	1529
2021 Q4	$29.8M	Hold	1,081,015	–	–	﹤0.01%	1638
2021 Q3	$28M	Sell	1,081,015 -1,000,000	-48%	-$26.7M	﹤0.01%	1674
2021 Q2	$56.5M	Buy	2,081,015 +170,480	+9%	+$4.16M	﹤0.01%	1375
2021 Q1	$44.7M	Buy	1,910,535 +1,910,200	+570,209%	+$38.6M	﹤0.01%	1451
2020 Q4	$5K	Hold	335	–	–	﹤0.01%	3425
2020 Q3	$4K	Hold	335	–	–	﹤0.01%	3333
2020 Q2	$3K	Hold	335	–	–	﹤0.01%	3300
2020 Q1	$3K	Hold	335	–	–	﹤0.01%	3322
2019 Q4	$5K	Hold	335	–	–	﹤0.01%	3391
2019 Q3	$6K	Hold	335	–	–	﹤0.01%	3351
2019 Q2	$7K	Hold	335	–	–	﹤0.01%	3296
2019 Q1	$8K	Hold	335	–	–	﹤0.01%	3154
2018 Q4	$7K	Sell	335 -43	-11%	-$890	﹤0.01%	3107
2018 Q3	$8K	Buy	+378	New	+$8.4K	﹤0.01%	3157
2018 Q1	–	Sell	-600,000	Closed	-$9.98M	–	2660
2017 Q4	$9.98M	Sell	600,000 -200,000	-25%	-$3.41M	﹤0.01%	1958
2017 Q3	$13.7M	Hold	800,000	–	–	﹤0.01%	1833
2017 Q2	$13M	Sell	800,000 -170,000	-18%	-$2.69M	﹤0.01%	1848
2017 Q1	$16.8M	Sell	970,000 -170,000	-15%	-$2.84M	﹤0.01%	1759
2016 Q4	$19.2M	Buy	1,140,000 +20,000	+2%	+$334K	﹤0.01%	1691
2016 Q3	$19.6M	Buy	+1,120,000	New	+$18.2M	﹤0.01%	1679

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Fidelity Investments's ANGO Position: Q1 2026 in Review

Fidelity Investments reduced its AngioDynamics (ANGO) stake by 26% in Q1 2026, selling an estimated $364K and leaving 94,748 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2854.

Fidelity Investments first reported a position in ANGO in Q3 2016 and has held it in 37 quarters since. The position peaked at $56.5M in Q2 2021. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Fidelity Investments held 94,748 shares of AngioDynamics worth $1.08M as of Q1 2026.
Fidelity Investments sold 33,624 AngioDynamics shares in Q1 2026, an estimated $364K.
AngioDynamics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2854 holding.
Fidelity Investments first reported a position in AngioDynamics in Q3 2016 and has held it in 37 quarters since.
Fidelity Investments's AngioDynamics position peaked at $56.5M in Q2 2021.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.